Bo Kruse's most recent trade in Y-Mabs Therapeutics Inc was a trade of 31,371 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on May 30, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, SECRY & TREAS. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 31,371 | 240,000 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, SECRY & TREAS. | Sale of securities on an exchange or to another person at price $ 12.07 per share. | 30 May 2024 | 31,371 | 210,877 (0%) | 0% | 12.1 | 378,648 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, SECRY & TREAS. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 30 May 2024 | 31,371 | 242,248 (0%) | 0% | 2 | 62,742 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, SECRY & TREAS. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 30 May 2024 | 28,629 | 239,506 (0%) | 0% | 2 | 57,258 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, SECRY & TREAS. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 28,629 | 271,371 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, SECRY & TREAS. | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 30 May 2024 | 28,629 | 210,877 (0%) | 0% | 12.0 | 344,407 | Common Stock |
| Y-Mabs Therapeutics Inc | Kruse Bo | EVP, CFO, SECRY & TREAS. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 108,900 | 108,900 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Kruse Bo | EVP, CFO, SECRY & TREAS. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 18,100 | 210,877 (0%) | 0% | 0 | Common Stock | |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secry & Treas. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 70,100 | 70,100 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secry & Treas. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 11,700 | 192,777 (0%) | 0% | 0 | Common Stock | |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 7.85 per share. | 22 Feb 2022 | 4,000 | 181,077 (0%) | 0% | 7.9 | 31,400 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas | Sale of securities on an exchange or to another person at price $ 7.97 per share. | 04 Feb 2022 | 4,000 | 185,077 (0%) | 0% | 8.0 | 31,880 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 9.84 per share. | 24 Jan 2022 | 4,000 | 189,077 (0%) | 0% | 9.8 | 39,360 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 17.12 per share. | 04 Jan 2022 | 4,000 | 193,077 (0%) | 0% | 17.1 | 68,480 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 16.36 per share. | 22 Dec 2021 | 4,000 | 197,077 (0%) | 0% | 16.4 | 65,440 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 85,000 | 85,000 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 18.09 per share. | 22 Nov 2021 | 4,000 | 205,077 (0%) | 0% | 18.1 | 72,360 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 27.54 per share. | 04 Nov 2021 | 4,000 | 209,077 (0%) | 0% | 27.5 | 110,160 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 25.94 per share. | 22 Oct 2021 | 4,000 | 213,077 (0%) | 0% | 25.9 | 103,760 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 28.78 per share. | 04 Oct 2021 | 4,000 | 217,077 (0%) | 0% | 28.8 | 115,120 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 30.82 per share. | 22 Sep 2021 | 4,000 | 221,077 (0%) | 0% | 30.8 | 123,280 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 32.03 per share. | 07 Sep 2021 | 4,000 | 225,077 (0%) | 0% | 32.0 | 128,120 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 28.60 per share. | 23 Aug 2021 | 4,000 | 229,077 (0%) | 0% | 28.6 | 114,400 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 33.72 per share. | 04 Aug 2021 | 4,000 | 233,077 (0%) | 0% | 33.7 | 134,880 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 34.50 per share. | 22 Jul 2021 | 4,000 | 237,077 (0%) | 0% | 34.5 | 138,000 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 34.15 per share. | 06 Jul 2021 | 4,000 | 241,077 (0%) | 0% | 34.2 | 136,600 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 36.17 per share. | 22 Jun 2021 | 4,000 | 245,077 (0%) | 0% | 36.2 | 144,680 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 33.48 per share. | 04 Jun 2021 | 4,000 | 249,077 (0%) | 0% | 33.5 | 133,920 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secretary & Treas. | Sale of securities on an exchange or to another person at price $ 35.61 per share. | 24 May 2021 | 4,000 | 253,077 (0%) | 0% | 35.6 | 142,440 | Common Stock |
| Y-Mabs Therapeutics Inc | Bo Kruse | EVP, CFO, Secy & Treas. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 72,350 | 72,350 | - | - | Employee Stock Option (right to buy) |